Fig. 1: S100A8 could be a therapeutic target against tumor progression. | Cancer Gene Therapy

Fig. 1: S100A8 could be a therapeutic target against tumor progression.

From: Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathway

Fig. 1

A Administration of recombinant S100A8 protein induces pulmonary recruitment of MDSCs from bone marrow. Data are shown as mean ± SD. *P < 0.05 compared with control (Cont). B Immunohistochemical analysis of S100A8 in subcutaneous LLC or MC38 tumors in C57BL6 mice. Scale bar: 200 µm.

Back to article page